Nutriproteomics for obesity research
International Journal of Development Research
Nutriproteomics for obesity research
Received 28th June, 2017; Received in revised form 19th July, 2017; Accepted 24th August, 2017; Published online 30th September, 2017
Copyright ©2017, Fernando César Rodrigues Brito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This study aimed to review findings of scientific articles which the use of proteomic tools made it possible to characterize the metabolic profile of obese individuals. We searched the electronic databases: Scielo, PubMed, Lilacs and capes. The time period was defined as 10 years, having as main keywords: proteomics, proteome, obesity, biomarkers. The use of serum proteomic techniques proposed prognostic markers for diseases and diseases resulting from obesity, such as diabetes and cardiovascular diseases. An analysis can be performed from hepatic tissue, muscle, adipose tissue and body fluids such as saliva, urine, serum and plasma. In the obesity treatment, monitoring the effects of physical exercise may reveal which proteins can modulate this physical activity, thus contributing to a deeper understanding of the physiological mechanisms. Although caloric restriction for weight loss is the main intervention for treatment, other interventions aimed at reducing inflammation in adipose tissue have been studied. Prospective analysis of representative and well-characterized populations to obtain statistical power is a limitation of proteomic studies. Therefore, to increase the relevance of studies in nutriproteomics, in particular studies on obesity, will certainly have to focus even more on application in humans.